Health Care • Medical/Dental Instruments
$57.65 ▼ -0.51
(-0.88%)
MKT CAP: $186.1M • VOL: 63.2K
52W L $29 52W H $77
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$48
MEDIAN
$65
MEAN
$66
HIGH
$78
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE PDEX TAPE
PDEX // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $69.76 | $66.30 | 2025-02-14 | $52.46 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $72.64 | $68.03 | 2025-02-06 | $54.19 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $65.72 | $63.42 | 2025-01-29 | $55.34 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $58.80 | — | 2025-01-17 | $56.50 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $50.73 | $54.77 | 2025-01-09 | $51.31 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $68.60 | $59.96 | 2024-12-18 | $50.16 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $55.92 | $58.23 | 2024-12-04 | $53.61 | -4.3% | 48% | C |